comparemela.com

Latest Breaking News On - ஆமி புளூமெண்டல் - Page 5 : comparemela.com

Burns & Levinson Partners Laura Studen and Ellen Zucker Ranked as Top Labor & Employment Plaintiffs Attorneys in Chambers USA 2021

Goulston & Storrs Attorney Kerry Spindler Chosen for 2021 LCLD Fellows Program

Goulston & Storrs Attorney Kerry Spindler Chosen for 2021 LCLD Fellows Program News provided by Share this article Share this article BOSTON, May 13, 2021 /PRNewswire/  Goulston & Storrs, an Am Law 200 firm, is pleased to announce that Kerry Spindler has been selected for the Leadership Council on Legal Diversity (LCLD) 2021 Fellows Program, which recognizes talented, mid-career attorneys who have exceptional leadership capabilities. Spindler will participate in LCLD s year-long, in-depth Fellows Program, which is devoted to relationship building, leadership training, and working with LCLD members and industry thought leaders to foster the advancement of the next generation of diverse attorneys. Kerry Spindler, a Director at Goulston & Storrs in Boston, has been selected for the Leadership Council on Legal Diversity 2021 Fellows Program, which recognizes talented, mid-career attorneys who have exceptional leadership capabilities. Spindler focuses her practice on sophisticated

Goulston & Storrs Attorneys Neema Chaiban and Linh Lingenfelter Selected for LCLD s 2021 Pathfinder Program

Goulston & Storrs Attorneys Neema Chaiban and Linh Lingenfelter Selected for LCLD s 2021 Pathfinder Program News provided by Share this article Share this article BOSTON, May 12, 2021 /PRNewswire/ Goulston & Storrs, an Am Law 200 firm, is pleased to announce that Neema Chaiban and Linh Lingenfelter have been selected for the Leadership Council on Legal Diversity (LCLD) 2021 Pathfinder Program, which trains high-performing, early-career attorneys in critical career development strategies including leadership and the building of professional networks. Neema Chaiban, a real estate lawyer at Goulston & Storrs, has been selected for the Leadership Council on Legal Diversity 2021 Pathfinder Program, which trains high-performing, early-career attorneys in critical career development strategies including leadership and the building of professional networks.

Goulston & Storrs Attorney Zev Gewurz Named a Northeast Trailblazer by The American Lawyer

Goulston & Storrs Attorney Zev Gewurz Named a Northeast Trailblazer by The American Lawyer News provided by Share this article Share this article BOSTON, May 3, 2021 /PRNewswire/  Goulston & Storrs, an Am Law 200 firm, is pleased to announce that Zev Gewurz, co-chair of the firm s Real Estate Group and International Investors Group, has been named a Northeast Trailblazer by The American Lawyer for his visionary work leading complex, sophisticated, first-of-their-kind real estate transactions . Zev Gewurz, co-chair of the Real Estate Group and International Investors Group at Goulston & Storrs in Boston, has been named a “Northeast Trailblazer” by The American Lawyer for his visionary work leading complex, sophisticated, first-of-their-kind real estate transactions.

Burns & Levinson Closes $4 2 Million Seed Financing for Anodyne Nanotech

Share this article Share this article BOSTON, May 3, 2021 /PRNewswire/ Burns & Levinson has closed a $4.2 million seed investment from Velocity Partners, Relativity Healthcare Fund and Big Pi Ventures for Anodyne Nanotech, Inc., a Boston-based biotechnology company developing differentiated, transdermal forms of high-value drugs. The investment will help expand the company s Hero Patch™ platform, which uses microneedle technology to deliver clinically meaningful doses of macromolecules and small molecules. The deal, which closed on April 8, was led by Josef Volman, who co-chairs the firm s Business Law Group, and Emmanuel Johnson. Josef Volman, co-chair of the Business Law Group at Burns & Levinson, led the $4.2 million seed investment deal from Velocity Partners, Relativity Healthcare Fund and Big Pi Ventures for client Anodyne Nanotech, Inc., a Boston-based biotechnology company developing differentiated, transdermal forms of high-value drugs.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.